At ASTRO 2025, researchers from Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, presented Phase 3 data showing that Respacio® from Qiming Venture Partners' portfolio company REUNION is safe and effective in cervical cancer radiotherapy.

Qiming Venture Partners' portfolio company WeRide.ai (NASDAQ:WRD) showcased its autonomous vehicle lineup at the World Intelligent Connected Vehicles Conference, with Robotaxi GXR & Robobus providing shuttle services across key locations, demonstrating commercial-scale mobility.

Qiming Venture Partners' portfolio company Abbisko Therapeutics (SEHK:2256) announced that longer-term efficacy and safety outcomes from the global phase 3 MANEUVER trial of pimicotinib (ABSK021) in patients with tenosynovial giant cell tumour were presented at the ESMO Congress 2025.

Qiming Venture Partners' portfolio company Biotree has introduced Thermo Fisher Scientific’s Orbitrap™ Astral™ Zoom, integrating it into its product line to create a high-performance platform connecting sample preparation and data analysis in proteomics research.

Qiming Venture Partners' portfolio company UBTECH Robotics (SEHK:9880) announced that Jifeng Yang has joined its smart logistics subsidiary UQI as Technical Partner & Co-CEO, leading industrial humanoid robots & L4 autonomous logistics vehicles R&D while driving global expansion.

Qiming Venture Partners' portfolio company SanegeneBio announced that its siRNA therapeutic SGB-9768 injection, which targets complement component C3, has received Orphan Drug Designation from the US Food and Drug Administration for the treatment of C3 glomerulopathy.

Qiming Venture Partners' portfolio company Insight Lifetech hosted the 2nd PCI Academy Workshop in Kraków, Poland, focusing on intracoronary imaging & physiology in complex PCI, highlighting the clinical value of FFR pullback & post-PCI assessment, and advanced IVUS-guided techniques.

Qiming Venture Partners' portfolio company Antengene (SEHK:6996) announced that the latest results from the ongoing Phase 1/2 CLINCH study of ATG-022 (CLDN18.2 ADC) were presented in a Poster Presentation at the European Society for Medical Oncology Congress 2025 in Germany.

Qiming Venture Partners' portfolio company Huimei Technology has partnered with The First Hospital of Hebei Medical University to launch the Joint R&D Center for Clinical Applications of AI Agents, advancing smart healthcare and AI integration in clinical practice. #QMPortfolio

Qiming Venture Partners' portfolio company Hesai Technology (NASDAQ:HSAI, SEHK:2525) has formed a strategic partnership with Fibocom to launch an advanced robotics multimodal perception and control solution that integrates LiDAR, stereo vision, and RTK technologies. #QMPortfolio

Qiming Venture Partners' portfolio company DST and LOGResearch have released the 2025 White Paper on Flexible Total Cost of Use (TCU) Configuration for Electric Light Trucks, introducing a new model based on business scenarios, flexible asset allocation, and integrated solutions.

Qiming Venture Partners' portfolio company HyperStrong (SHSE: 688411) has opened its office in BGC Financial District, Manila, Philippines and secured a 185 MWh large-scale energy storage project, marking a key step in its Southeast Asia expansion. #QMPortfolio

At IEEE/RSJ International Conference on Intelligent Robots and Systems, Qiming Venture Partners' portfolio company UBTECH Robotics (SEHK:9880) presented the latest research on humanoid stereo vision, with experts also sharing insights on Thinker model's architecture, roadmap,etc.

Qiming Venture Partners' portfolio company Berry Genomics (SZSE:000710) provided single-cell multiomics & 10x spatial transcriptomics support for a study published in Annals of the Rheumatic Diseases by University of Science & Technology of China and its 1st Affiliated Hospital.

Qiming Venture Partners' portfolio company 52TOYS showcased collaborations with global IPs, its signature BeastBox series, and new original collections at the China Toy Expo. Since 2017, 52TOYS has expanded globally across Southeast Asia, Japan, Korea, and North America.

Qiming Venture Partners' portfolio company UBTECH Robotics (SEHK:9880) has received Platinum Award, the highest honor at 2025 Muse Design Awards, for its next-generation industrial humanoid robot Walker S2 as the only humanoid robot in the world to earn this distinction in 2025.

Qiming Venture Partners' portfolio company Dearer Group has launched silicone hydrogel colored lenses with high oxygen permeability for greater eye comfort, plus patented inner film coating and multi-curve design for safety and stability. #QMPortfolio

Qiming Venture Partners' portfolio company VINNO Ultrasound showcased its VINNO 10P portable ultrasound at the 10th National Critical Ultrasonography Congress, streamlining complex critical ultrasound exams and enabling doctors to make fast, precise decisions in urgent settings.

Qiming Venture Partners' portfolio company Hesai Technology (NASDAQ:HSAI, SEHK:2525) powers the new Tank 400 Hi4-Z & Hi4-T from Great Wall Motor with advanced lidar. The latest Tank 400 series integrates 27 ADAS sensors for full-scenario assisted driving with city & highway NOA.

Qiming Venture Partners' portfolio company KouTech showcased its Kai microsurgical robotic system at the 13th Annual Meeting of the Robotic-Assisted Microsurgical & Endoscopic Society. Prof. Isao Koshima praised its advanced engineering-clinical integration & next-gen usability.